Anti-CCHL/ HCCS/ LSDMCA1 functional antibody

Anti-CCHL/ HCCS/ LSDMCA1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to HCCS/HCCS products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1398-Ab-1/ GM-Tg-hg-SE1398-Ab-2Anti-Human HCCS monoclonal antibodyHuman
GM-Tg-rg-SE1398-Ab-1/ GM-Tg-rg-SE1398-Ab-2Anti-Rat HCCS monoclonal antibodyRat
GM-Tg-mg-SE1398-Ab-1/ GM-Tg-mg-SE1398-Ab-2Anti-Mouse HCCS monoclonal antibodyMouse
GM-Tg-cynog-SE1398-Ab-1/ GM-Tg-cynog-SE1398-Ab-2Anti-Cynomolgus/ Rhesus macaque HCCS monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1398-Ab-1/ GM-Tg-felg-SE1398-Ab-2Anti-Feline HCCS monoclonal antibodyFeline
GM-Tg-cang-SE1398-Ab-1/ GM-Tg-cang-SE1398-Ab-2Anti-Canine HCCS monoclonal antibodyCanine
GM-Tg-bovg-SE1398-Ab-1/ GM-Tg-bovg-SE1398-Ab-2Anti-Bovine HCCS monoclonal antibodyBovine
GM-Tg-equg-SE1398-Ab-1/ GM-Tg-equg-SE1398-Ab-2Anti-Equine HCCS monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1398-Ab-1/ GM-Tg-hg-SE1398-Ab-2; GM-Tg-rg-SE1398-Ab-1/ GM-Tg-rg-SE1398-Ab-2;
GM-Tg-mg-SE1398-Ab-1/ GM-Tg-mg-SE1398-Ab-2; GM-Tg-cynog-SE1398-Ab-1/ GM-Tg-cynog-SE1398-Ab-2;
GM-Tg-felg-SE1398-Ab-1/ GM-Tg-felg-SE1398-Ab-2; GM-Tg-cang-SE1398-Ab-1/ GM-Tg-cang-SE1398-Ab-2;
GM-Tg-bovg-SE1398-Ab-1/ GM-Tg-bovg-SE1398-Ab-2; GM-Tg-equg-SE1398-Ab-1/ GM-Tg-equg-SE1398-Ab-2
Products NameAnti-HCCS monoclonal antibody
Formatmab
Target NameHCCS
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-HCCS benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1398-Ag-1Recombinant multi-species CCHL/ HCCS/ LSDMCA1 protein
    ORF Viral VectorpGMLP004992human HCCS Lentivirus plasmid
    ORF Viral VectorvGMLP004992human HCCS Lentivirus particle
    ORF Viral VectorpGMLPm000847mouse Hccs Lentivirus plasmid
    ORF Viral VectorvGMLPm000847mouse Hccs Lentivirus particle


    Target information

    Target IDGM-SE1398
    Target NameHCCS
    Gene ID3052,15159,317444,709878,480834,101085440,506250,100053680
    Gene Symbol and SynonymsCCHL,HCCS,LSDMCA1,MCOPS7,MLS,RGD1563855
    Uniprot AccessionP53701,A5PJG7
    Uniprot Entry NameCCHL_HUMAN,CCHL_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseCancer
    Gene EnsemblENSG00000004961
    Target ClassificationTumor-associated antigen (TAA)

    The target: HCCS, gene name: HCCS, also named as CCHL, LSDMCA1, MCOPS7, MLS. The protein encoded by this gene is an enzyme that covalently links a heme group to the apoprotein of cytochrome c. Defects in this gene are a cause of microphthalmia syndromic type 7 (MCOPS7). Three transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jan 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.